Literature DB >> 29725524

Significance of data analysis in the quality control of prenatal screening for Down syndrome.

Yahong Li1, Xiaojuan Zhang1, Dongyang Hong1, Xianwei Guan1, Shaolei Lv2, Yun Sun1, Tao Jiang1.   

Abstract

Dual detection of α-fetoprotein (AFP) and free β-human chorionic gonadotropin (β-HCG) is a common screening method for Down syndrome in the second trimester and its efficacy is assessed by false-positive rate (FPR). The present study aimed to investigate the effects of the bias in median multiple of the median (mMoM) values of AFP and free β-HCG on FPR. The bias in mMoM values of AFP and free β-HCG and the bias in mMoM values under different gestational ages and weight groups were analyzed. Median equations were adjusted, and medians in LifeCycle software were replaced by local medians. Following two adjustments of the median equations, all indices including FPR, mMoM values of markers and mMoM values under different gestational ages and weight groups generally reached an ideal state. In conclusion, abnormal bias in mMoM values may prompt aberrant application of median equations, and regular monitoring of these indicators may be important for quality control in prenatal screening.

Entities:  

Keywords:  Down syndrome; prenatal screening; quality control

Year:  2018        PMID: 29725524      PMCID: PMC5920491          DOI: 10.3892/br.2018.1078

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  14 in total

1.  Effect on Down syndrome screening performance of adjusting for marker levels in a previous pregnancy.

Authors:  Nicholas J Wald; Isobel M Barnes; Ruthie Birger; Wayne Huttly
Journal:  Prenat Diagn       Date:  2006-06       Impact factor: 3.050

2.  False positive rate of serum markers for Down syndrome screening: does transportation have any effect?

Authors:  Supatra Sirichotiyakul; Suchaya Luewan; Rattanaporn Sekararith; Theera Tongsong
Journal:  J Med Assoc Thai       Date:  2012-02

3.  Monitoring surgical and medical outcomes: the Bernoulli cumulative SUM chart. A novel application to assess clinical interventions.

Authors:  G Leandro; N Rolando; G Gallus; K Rolles; A K Burroughs
Journal:  Postgrad Med J       Date:  2005-10       Impact factor: 2.401

4.  Factors influencing prenatal screening for Down's syndrome: evidence from Zhejiang (China).

Authors:  Jiayan Huang; Yingyao Chen; Raymond W Pong
Journal:  Asia Pac J Public Health       Date:  2012-10-23       Impact factor: 1.399

5.  Second-trimester maternal serum screening for Down's syndrome: free beta-human chorionic gonadotrophin (HCG) and alpha-fetoprotein, with or without unconjugated oestriol, compared with total HCG, alpha-fetoprotein and unconjugated oestriol.

Authors:  P Extermann; P Bischof; P Marguerat; B Mermillod
Journal:  Hum Reprod       Date:  1998-01       Impact factor: 6.918

6.  Second-trimester maternal serum quadruple test for Down syndrome screening: a Taiwanese population-based study.

Authors:  S W Steven Shaw; Shin-Yu Lin; Chia-Hui Lin; Yi-Ning Su; Po-Jen Cheng; Chien-Nan Lee; Chih-Ping Chen
Journal:  Taiwan J Obstet Gynecol       Date:  2010-03       Impact factor: 1.705

7.  Combined detection of α-fetoprotein and free β-human chorionic gonadotropin in screening for trisomy 21 and management of cases in the moderate risk value range.

Authors:  Yahong Li; Xiaojuan Zhang; Yun Sun; Dongyang Hong; Yanyun Wang; Zhengfeng Xu; Tao Jiang
Journal:  Mol Clin Oncol       Date:  2017-07-31

8.  The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.

Authors:  N Cenk Sayin; M Tunç Canda; Nefize Ahmet; Sezer Arda; Necdet Süt; Füsun G Varol
Journal:  Arch Gynecol Obstet       Date:  2007-07-25       Impact factor: 2.344

9.  Mid-trimester maternal serum HCG and alpha fetal protein levels: clinical significance and prediction of adverse pregnancy outcome.

Authors:  Georgios Androutsopoulos; Panagiotis Gkogkos; Georgios Decavalas
Journal:  Int J Endocrinol Metab       Date:  2013-04-01

10.  Noninvasive screening tools for Down syndrome: a review.

Authors:  Meagan Smith; Jeannie Visootsak
Journal:  Int J Womens Health       Date:  2013-03-06
View more
  1 in total

1.  External Quality Assessment of Maternal Serum Levels of Alpha-Fetoprotein, Free Beta-Human Chorionic Gonadotropin, and Unconjugated Estriol in Detecting Down Syndrome and Neural Tube Defects in the Second Trimester of 87 Maternal Serum Samples, Based on 105-139 Days.

Authors:  Yiming Chen; Yijie Chen; Yezhen Shi; Wenwen Ning; Xiaoying Wang; Liyao Li; Huimin Zhang
Journal:  Med Sci Monit       Date:  2022-04-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.